Impact of BMGIM Music Therapy on Emotional State in Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial

Background. Patients with inflammatory bowel disease (IBD) have a high prevalence ofemotional disturbances which worsen the symptoms of the disease. As a therapeutic alternative thatis part of a comprehensive care alongside medication, the Bonny Method of Guided Imagery andMusic (BMGIM) music-assisted therapy has achieved promising emotional improvements in patientswith chronic diseases. The objective of the study was to determine the impact of a treatment based ona BMGIM group adaptation on patients with inflammatory bowel disease (IBD) and their emotionalstate, therefore analyzing state of mind, quality of life, anxiety, depression, immunocompetence as amarker of well-being, and levels of acute and chronic stress. Methods. Longitudinal, prospective,quantitative, and experimental study including 43 patients with IBD divided into an interventiongroup (22 patients), who received eight sessions over eight weeks, and a control group (21 patients).A saliva sample was taken from each patient before and after each session in order to determinecortisol and IgA levels. Similarly, a hair sample was taken before the first and after the last session todetermine the cumulative cortisol level. All molecules were quantified using the ELISA immunoassaytechnique. In addition, patients completed several emotional state questionnaires: HADS, MOOD,and CCVEII. Results. An improvement was observed in the following states of mind: sadness, fear,anger, and depression. No significant effect was observed in state of mind in terms of happinessor anxiety, in the levels of cortisol in hair, and in patients’ perceived quality of life. A reduction incortisol was observed in saliva, although this did not significantly affect the IgA titer. Conclusions.BMGIM seems to improve the emotional state of patients with IBD.Medicin

Psychosocial and sociodemographic predictors of attrition in a longitudinal study of major depression in primary care: the predictD-Spain study

Few data exist on the psychosocial factors associated with attrition in longitudinal surveys. This study was undertaken to determine psychosocial and sociodemographic predictors of attrition from a longitudinal study of the onset and persistence of episodes of major depression in primary care

Predicting the onset and persistence of episodes of depression in primary health care. The predictD-Spain study: Methodology

Background: The effects of putative risk factors on the onset and/or persistence of depression remain unclear. We aim to develop comprehensive models to predict the onset and persistence of episodes of depression in primary care. Here we explain the general methodology of the predictD-Spain study and evaluate the reliability of the questionnaires used. Methods: This is a prospective cohort study. A systematic random sample of general practice attendees aged 18 to 75 has been recruited in seven Spanish provinces. Depression is being measured with the CIDI at baseline, and at 6, 12, 24 and 36 months. A set of individual, environmental, genetic, professional and organizational risk factors are to be assessed at each follow-up point. In a separate reliability study, a proportional random sample of 401 participants completed the test-retest (251 researcher-administered and 150 self-administered) between October 2005 and February 2006. We have also checked 118,398 items for data entry from a random sample of 480 patients stratified by province. Results: All items and questionnaires had good test-retest reliability for both methods of administration, except for the use of recreational drugs over the previous six months. Cronbach's alphas were good and their factorial analyses coherent for the three scales evaluated (social support from family and friends, dissatisfaction with paid work, and dissatisfaction with unpaid work). There were 191 (0.16%) data entry errors. Conclusion: The items and questionnaires were reliable and data quality control was excellent. When we eventually obtain our risk index for the onset and persistence of depression, we will be able to determine the individual risk of each patient evaluated in primary health care.The research in Spain was funded by grants from the Spanish Ministry of Health (grant FIS references: PI04/1980, PI0/41771, PI04/2450, and PI06/1442), Andalusian Council of Health (grant references: 05/403, 06/278 and 08/0194), and the Spanish Ministry of Education and Science (grant reference SAF 2006/07192). The Malaga sample, as part of the predictD-International study, was also funded by a grant from The European Commission (reference QL4-CT2002-00683)

Aula Farmacia Práctica en asma

El aula farmacia práctica en el paciente asmático es un espacio destinado a los servicios farmacéuticos para proporcionar las herramientas necesarias para la educación farmacéutica en el manejo de los inhaladores y la prevención de las crisis asmáticas en los pacientes atendidos en la farmacia. En los pacientes que lo requieran y en colaboración con el equipo de salud, el farmacéutico podrá ofrecer el servicio de seguimiento farmacoterapéutico personalizado, para controlar el uso efectivo y seguro de los medicamentosMQD2010-00144U

Aula Farmacia Práctica en asma

El aula farmacia práctica en el paciente asmático es un espacio destinado a los servicios farmacéuticos para proporcionar las herramientas necesarias para la educación farmacéutica en el manejo de los inhaladores y la prevención de las crisis asmáticas en los pacientes atendidos en la farmacia. En los pacientes que lo requieran y en colaboración con el equipo de salud, el farmacéutico podrá ofrecer el servicio de seguimiento farmacoterapéutico personalizado, para controlar el uso efectivo y seguro de los medicamentosMQD2010-00144U

Servicio farmacéutico de deshabituación al tabaco

Se describe qué es el tabaquismo, con que enfermedades se asocia, el proceso de deshabituación tabáquica,fases del mismo e intervenciones farmacéuticas. Materiales y herramientas necesarios para prestar el servicio de deshabituación al tabaco. Técnica, tests de valoración, plan de acción y registros. Manejo de la terapia sustitutiva de la nicotina.MQD2010-00144-U

Servicio farmacéutico de deshabituación al tabaco

Se describe qué es el tabaquismo, con que enfermedades se asocia, el proceso de deshabituación tabáquica,fases del mismo e intervenciones farmacéuticas. Materiales y herramientas necesarios para prestar el servicio de deshabituación al tabaco. Técnica, tests de valoración, plan de acción y registros. Manejo de la terapia sustitutiva de la nicotina.MQD2010-00144-U